Adverse Drug Reaction News Bulletins
ADR News Bulletin 2009 December (Volume 11 Number 3)
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
1 December 2009
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Monitoring the safety profile of Influenza A/H1N1 (2009) vaccines
Suspension of sales of dextropropoxyphene-containing products
New online search on illegal health products
Important drug interactions
Compliance to the safety monitoring protocols of the 'RevAssure Programme' of Lenalidomide (Revlimid®)
Tinzaparin (Innohep®) and risk of death in the elderly with renal impairment
Summary of safety advisories issued by HSA and pharmaceutical companies
Package insert amendments reflecting safety issues
Local experience with oseltamivir (Tamiflu®)
Click on the link below to download the issue in pdf: